To amend the Employee Retirement Income Security Act of 1974 to increase transparency of group health plan data, prevent discrimination, and for other purposes.
Summary
HR9486, a bill to increase transparency and prevent discrimination in group health plans under ERISA, was referred to the House Education and Workforce Committee on June 25, 2026. The bill imposes new data reporting and non-discrimination requirements on employers and insurers, creating compliance cost headwinds for managed care organizations like UnitedHealth, Humana, and Cigna. At this early legislative stage, market impact is minimal but bears watching if the bill advances.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9486 is at the referral stage with no funding; near-term market impact is negligible.
- 2.Major health insurers face potential compliance costs if the bill advances, but legislative odds are low.
- 3.No direct revenue impact is estimable given the procedural status.
Market Implications
Healthcare payers and PBMs may face modest headwinds from increased regulatory oversight if HR9486 gains traction. However, given the early stage and lack of bipartisan support, the market is unlikely to price in any impact yet. , , and remain driven by fundamentals and broader healthcare policy themes.
Full Analysis
On June 25, 2026, Representative Mark Takano (D-CA) introduced HR9486, which amends ERISA to increase transparency of group health plan data and prevent discrimination. The bill is in the earliest legislative stage—referred to the House Committee on Education and Workforce—with no committee markup or companion bill in the Senate. The money trail is indirect: the bill mandates new reporting requirements for group health plans and prohibits discriminatory plan designs, but authorizes no specific funding. Compliance costs would be borne by employers and health insurers. The mechanism is regulatory rather than financial: plans must disclose detailed data on coverage denials, network adequacy, and plan design, while anti-discrimination provisions target benefits that disproportionately affect protected classes. For UnitedHealth, Humana, and Cigna, the primary impact is increased administrative burden on their group health plan businesses and pharmacy benefit managers (OptumRx, Express Scripts). Given the early stage and absence of a price tag, the bill's passage chance is low in the 119th Congress. However, if it gains co-sponsors or a companion bill in the Senate, it could signal a regulatory shift toward tighter oversight of employer-sponsored plans. Structural winners are not yet identifiable; the only near-term effect is a slight bearish tilt for large insurers due to compliance uncertainty.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend the Employee Retirement Income Security Act of 1974 to ensure plan fiduciaries have access to de-identified information relating to health claims, and for other purposes.
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require the displaying of claim denial rates.
Premium Transparency Act
To amend the Patient Protection and Affordable Care Act to provide that qualified health plans are not required to use a provider network.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →